Chiou S-H et al., Pancreatic cancer modeling with viral-vectors and in vivo CRISPR/Cas9-mediated somatic genome editing.  Genes and Development, Volume 29(14);1576-85, 2015


Tasic B et al., Extensions of MADM (Mosaic Analysis with Double Markers) in Mice Plos One 7(3): e33332, 2012


Tasic B et al., Site-specific integrase-mediated transgenesis in mice via pronuclear injection. PNAS 7902-7907, 108(19), 2011


Zeng H et al., Rescue partial differentiated mouse ES cells using GSK-3 inhibitor. ISSCR/CSH Cellular Programs and Reprogramming, Suzhou China, Oct, 2011


Lesnik J et al., Registered report: Melanoma exosomes educate bone marrow progenitor cells toward a prometastatic phenotype through MET. ELife, 5: 1-15, 2016 


Jorge Moreno-Cuevas, et al.: Fluorescence-activated On-Chip Cell Culture Sorting (O3CS): Smart Petri Dish. Submitted, 2016.


Hua Fan-Minogue, et al.: A novel receptor mediates the tumorigenesis of squamous cell lung cancers. Submitted, 2016.


Yonezawa A, et al.: Boosting cancer immunotherapy with anti-CD137 antibody therapy. Clinical Cancer Research, 21(14):3113-20, 2015.


Batista P, et al.: m(6)A RNA modification controls cell fate transition in mammalian embryonic stem cells. Cell Stem Cell 15(6):707-19, 2014


Townley H, et al.: In vivo demonstration of enhanced radiotherapy using rare earth doped titania nanoparticles. Nanoscale, 4(16):5043-50, 2012.


Khana M, et al.: Discovery of a novel class of covalent inhibitor for aldehyde dehydrogenases. Journal of Biological Chemistry, 286(50):43486-94, 2011.


Sirota M, et al: Discovery and preclinical validation of drug indications using compendia of public gene expression data. Science Translational Medicine 3, 96ra77, 1-10, 2011.


Gupta RA, et al.: Reprogramming breast cancer epigenome and promotion of metastasis by the long noncoding RNA HOTAIR. Nature 464, 1071-01078, 2010.











All services need to be requested through iLab



Prof. Vittorio Sebastiano, PhD

Assistant professor of Obstetrics & Gynecology




Dr. Hong Zeng, MD, PhD

Contact for genome editing and mouse line services



Research Scientist, Tumor model group leader

Nirk Quispe Calla, MD

Contact for tumor model services